What is Roivant Sciences's D&A?

Roivant Sciences (ROIV) reported D&A of $638K in Q1 2026.

How has Roivant Sciences's D&A changed year-over-year?

Roivant Sciences's D&A decreased by 55.2% year-over-year, from $1.43M to $638K.

What is the long-term trend for Roivant Sciences's D&A?

Over 3 years (2022 to 2025), Roivant Sciences's D&A has grown at a -43.8% compound annual growth rate (CAGR), from $18.86M to $3.35M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Roivant Sciences ROIV D&A

D&A at other companies

AmgenAMGN

$1.12B-19.5%

ModernaMRNA

$59M+51.3%

Immunovant, Inc.IMVT

$96K-11.9%

Bristol-Myers SquibbBMY

$594M-41.3%

RegenxbioRGNX

$3.86M-2.5%

RevvityRVTY

$105.06M+7.8%

Other financials

Income statement

See full

Revenue$2.5M-66.7%

Operating income-$339.2M-23.6%

Net income-$265.9M-257%

EPS (diluted)-$0.38-265%

Balance sheet

See full

Cash & equivalents$1.4B+1,411%

Total debt$107.4M+7.3%

Total equity$4.5B-3.4%

Total assets$5.7B+5.0%

Cash flow

See full

Operating cash flow-$163.8M+5.1%

CapEx$1.3M+55.5%

Free cash flow-$165.1M+4.8%

Valuation

See full

Market cap$25.25B+226%

Enterprise value$23.93B+209%

P/S3,056.5×+2,723×

Profitability

See full

Operating margin-9,130.5%-13,995pp

Net margin-6,079.9%-6,193pp

FCF margin-9,183.5%-17,093pp

Returns & leverage

See full

Return on equity-17.1%-17.7pp

Debt / equity0×0.0×

Current ratio18.4×-15.1×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Roivant Sciences's D&A?: Roivant Sciences (ROIV) reported D&A of $638K in Q1 2026.
How has Roivant Sciences's D&A changed year-over-year?: Roivant Sciences's D&A decreased by 55.2% year-over-year, from $1.43M to $638K.
What is the long-term trend for Roivant Sciences's D&A?: Over 3 years (2022 to 2025), Roivant Sciences's D&A has grown at a -43.8% compound annual growth rate (CAGR), from $18.86M to $3.35M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.